| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1468 | 2020 |
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo YJ Hou, S Chiba, P Halfmann, C Ehre, M Kuroda, KH Dinnon III, SR Leist, ... Science 370 (6523), 1464-1468, 2020 | 899 | 2020 |
| SARS-CoV-2 infection of the oral cavity and saliva N Huang, P Pérez, T Kato, Y Mikami, K Okuda, RC Gilmore, CD Conde, ... Nature medicine 27 (5), 892-903, 2021 | 693 | 2021 |
| A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice SR Leist, KH Dinnon, A Schäfer, VT Longping, K Okuda, YJ Hou, A West, ... Cell 183 (4), 1070-1085. e12, 2020 | 486 | 2020 |
| Localization of secretory mucins MUC5AC and MUC5B in normal/healthy human airways K Okuda, G Chen, DB Subramani, M Wolf, RC Gilmore, T Kato, ... American journal of respiratory and critical care medicine 199 (6), 715-727, 2019 | 233 | 2019 |
| Human distal lung maps and lineage hierarchies reveal a bipotent progenitor P Kadur Lakshminarasimha Murthy, V Sontake, A Tata, Y Kobayashi, ... Nature 604 (7904), 111-119, 2022 | 149 | 2022 |
| Secretory cells dominate airway CFTR expression and function in human airway superficial epithelia K Okuda, H Dang, Y Kobayashi, G Carraro, S Nakano, G Chen, T Kato, ... American journal of respiratory and critical care medicine 203 (10), 1275-1289, 2021 | 134 | 2021 |
| Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis W Rao, S Wang, M Duleba, S Niroula, K Goller, J Xie, R Mahalingam, ... Cell 181 (4), 848-864. e18, 2020 | 109 | 2020 |
| IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis G Chen, L Sun, T Kato, K Okuda, MB Martino, A Abzhanova, JM Lin, ... The Journal of clinical investigation 129 (10), 4433-4450, 2019 | 106 | 2019 |
| Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection SB Biering, SA Sarnik, E Wang, JR Zengel, SR Leist, A Schäfer, ... Nature genetics 54 (8), 1078-1089, 2022 | 65 | 2022 |
| XBP1S regulates MUC5B in a promoter variant–dependent pathway in idiopathic pulmonary fibrosis airway epithelia G Chen, CMP Ribeiro, L Sun, K Okuda, T Kato, RC Gilmore, MB Martino, ... American journal of respiratory and critical care medicine 200 (2), 220-234, 2019 | 63 | 2019 |
| SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice KH Dinnon III, SR Leist, K Okuda, H Dang, EJ Fritch, KL Gully, ... Science translational medicine 14 (664), eabo5070, 2022 | 58 | 2022 |
| Prevalence and mechanisms of mucus accumulation in COVID-19 lung disease T Kato, T Asakura, CE Edwards, H Dang, Y Mikami, K Okuda, G Chen, ... American journal of respiratory and critical care medicine 206 (11), 1336-1352, 2022 | 33 | 2022 |
| Evaluation of clinical characteristics and prognosis of chronic pulmonary aspergillosis depending on the underlying lung diseases: Emphysema vs prior tuberculosis K Koyama, N Ohshima, J Suzuki, M Kawashima, K Okuda, R Sato, ... Journal of Infection and Chemotherapy 21 (11), 795-801, 2015 | 26 | 2015 |
| An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2 KC Barnett, Y Xie, T Asakura, D Song, K Liang, SA Taft-Benz, H Guo, ... Cell Host & Microbe 31 (2), 243-259. e6, 2023 | 24 | 2023 |
| A case of Meigs’ syndrome with preceding pericardial effusion in advance of pleural effusion K Okuda, S Noguchi, O Narumoto, M Ikemura, Y Yamauchi, G Tanaka, ... BMC pulmonary medicine 16, 1-6, 2016 | 24 | 2016 |
| Clinical and angiographic characteristics of 35 patients with cryptogenic hemoptysis T Ando, M Kawashima, K Masuda, K Takeda, K Okuda, J Suzuki, ... Chest 152 (5), 1008-1014, 2017 | 22 | 2017 |
| FOXL1 regulates lung fibroblast function via multiple mechanisms N Miyashita, M Horie, HI Suzuki, M Saito, Y Mikami, K Okuda, RC Boucher, ... American journal of respiratory cell and molecular biology 63 (6), 831-842, 2020 | 20 | 2020 |
| Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications OF McElvaney, T Asakura, SL Meinig, JL Torres-Castillo, RS Hagan, ... EBioMedicine 77, 2022 | 19 | 2022 |
| Associations of COVID-19 symptoms with omicron subvariants BA. 2 and BA. 5, host status, and clinical outcomes in Japan: a registry-based observational study S Nakakubo, N Kishida, K Okuda, K Kamada, M Iwama, M Suzuki, ... The Lancet Infectious Diseases 23 (11), 1244-1256, 2023 | 17 | 2023 |
